The carboxy therapy market is estimated to be valued at USD 107.7 Mn in 2024 and is expected to reach USD 228.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.
Report Coverage |
Report Details |
Base Year: |
2023 |
Market Size in 2024: |
US$ 107.7 Mn |
Historical Data for: |
2019 To 2023 |
Forecast Period: |
2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: |
11.40% |
2031 Value Projection: |
US$ 228.7 Mn |
Figure. Carboxy Therapy Market Share (%), By Region 2024
![Carboxy Therapy Market - IMG1](/sample/img/COH1477248-f1.webp)
Carboxy therapy, also known as carbon dioxide therapy, is a minimally invasive cosmetic procedure that uses carbon dioxide gas to enhance the appearance of skin. The non-surgical treatment aims to reduce signs of aging, diminish cellulite and stretch marks. In carboxy therapy, carbon dioxide gas in its gaseous or liquid states is injected into the deep layers of the skin using a fine needle. The gas stimulates circulation and collagen production, thereby improving skin tone and texture over time. It is a popular anti-aging technique in some European countries and is gaining popularity as an alternative to cosmetic procedures like laser resurfacing.
Market Dynamics:
The global carboxy therapy market growth is driven by the rising demand for non-invasive aesthetic procedures for skin improvement. Furthermore, growing awareness about the benefits of carboxy therapy in reducing appearance of ageing signs, cellulite, scars, and stretch marks is augmenting the market growth. The easy availability of these procedures, minimal risks, and negligible downtime involved in carboxy therapy are further propelling its adoption. However, lack of awareness regarding carboxy therapy in developing nations and preference for other skin procedures are restraining the market growth. Development of advanced treatment protocols and devices for carboxy therapy is expected to present lucrative growth opportunities for market players.
Key Features of the Study:
- This report provides in-depth analysis of the global carboxy therapy market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global carboxy therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes BodyHt, UNITRONIC, DermoEquipos, Alvi Prague, Oxxot, Faireal Medical Laser, DTA Medical, Wavemed, NHC Medical & Beauty, Cosmo Pro, Nick Fanavaran Plasma Company, Beijing Jontelaser Technologies Co., Ltd., MBE Medical Division, and Mezopharma
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global carboxy therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global carboxy therapy market
Detailed Segmentation-
- Device Type:
- Application:
- Stretch marks
- Cellulite
- Alopecia
- Dark Eye Circles
- Scars & Wrinkles
- Others
- Body Part
- Face
- Eyelids
- Neck
- Stomach
- Buttocks
- Others
- End User
- Hospitals
- Dermatology Clinics
- Ambulatory Surgery Centers
- Others
- Company Profiles:
- BodyHt
- UNITRONIC
- DermoEquipos
- Alvi Prague
- Oxxot
- Faireal Medical Laser
- DTA Medical
- Wavemed
- NHC Medical & Beauty
- Cosmo Pro
- Nick Fanavaran Plasma Company
- Beijing Jontelaser Technologies Co., Ltd.
- MBE Medical Division
- Mezopharma